Bristol Myers Squibb: Clinical Trials & Research Profile
Biopharma Industry (Princeton, NJ) · Primary Focus: Oncology and Hematology
| Clinical Trial Metric | Verified Public Record |
|---|---|
| Organization Type | Consolidated Trial Sponsor |
| Institutional Sector & Location | Biopharma Industry (Princeton, NJ) |
| Primary Therapeutic Area | Oncology and Hematology |
| Active Phase II & III Studies | 132 active (69 recruiting now) |
| Total Tracked Studies (2018 to 2026) | 272 (195 with California sites) |
| Completed vs Early-Stopped Studies | 88 completed / 52 stopped (19.1% stop rate) |
| Median Closed Enrollment | 160 participants |
| FDA Drugs@FDA Original Approvals | 78 all-time (14 from 2018 to 2026) |
| Physical Hospital Site Disclosure | 97.3% named hospital slots |
Related Filings Across Meru Platforms
Verified cross-ledger federal filings for Bristol Myers Squibb across sibling Meru public-data platforms.
Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI -> · AI for Healthcare · Healthcare Price & Patent Cliff Crosswalk